ConductScience.org, home
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
API referenceFor AI assistants

Trial · NCT02795767

Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCohort A: 1.5 mg/kg Emicizumab QW68
Overall StudySTARTEDCohort B: 3 mg/kg Emicizumab Q2W10
Overall StudySTARTEDCohort C: 6 mg/kg Emicizumab Q4W10
Overall StudyReceived at Least One Dose of EmicizumabCohort A: 1.5 mg/kg Emicizumab QW68
Overall StudyReceived at Least One Dose of EmicizumabCohort B: 3 mg/kg Emicizumab Q2W10
Overall StudyReceived at Least One Dose of EmicizumabCohort C: 6 mg/kg Emicizumab Q4W10
Overall StudyDose Up-Titrated to 3 mg/kg QWCohort A: 1.5 mg/kg Emicizumab QW0
Overall StudyDose Up-Titrated to 3 mg/kg QWCohort B: 3 mg/kg Emicizumab Q2W0
Overall StudyDose Up-Titrated to 3 mg/kg QWCohort C: 6 mg/kg Emicizumab Q4W3
Overall StudyCompleted 52 Weeks in StudyCohort A: 1.5 mg/kg Emicizumab QW67
Overall StudyCompleted 52 Weeks in StudyCohort B: 3 mg/kg Emicizumab Q2W10
Overall StudyCompleted 52 Weeks in StudyCohort C: 6 mg/kg Emicizumab Q4W9
Overall StudyCOMPLETEDCohort A: 1.5 mg/kg Emicizumab QW67
Overall StudyCOMPLETEDCohort B: 3 mg/kg Emicizumab Q2W10
Overall StudyCOMPLETEDCohort C: 6 mg/kg Emicizumab Q4W10
Overall StudyNOT COMPLETEDCohort A: 1.5 mg/kg Emicizumab QW1
Overall StudyNOT COMPLETEDCohort B: 3 mg/kg Emicizumab Q2W0
Overall StudyNOT COMPLETEDCohort C: 6 mg/kg Emicizumab Q4W0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02795767/flow

API referenceFor AI assistants